Influence of biological agents on cardiovascular disease in rheumatoid arthritis
European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I
EULAR recommendations for calcium pyrophosphate deposition. Part II
Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis
Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis
Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER)
Methods of tophus assessment in clinical trials of chronic gout
The paediatric wrist revisited
Disease activity score-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis
Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry
Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden
Predictive factors of hand radiographic lesions in systemic sclerosis
Effectiveness of initial treatment allocation based on expert opinion for prevention of rapid radiographic progression in daily practice of an early RA cohort
A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort
Parity, time since last live birth and long-term functional outcome
Mitochondrial DNA haplogroups and serum levels of proteolytic enzymes in patients with osteoarthritis
Mutations of the cystic fibrosis gene in patients with bronchiectasis associated with rheumatoid arthritis
Tumour necrosis factor alpha-driven IL-32 expression in rheumatoid arthritis synovial tissue amplifies an inflammatory cascade
NLRP1 influences the systemic sclerosis phenotype
Global effects of fluvastatin on the prothrombotic status of patients with antiphospholipid syndrome
Matrix metalloproteinase 17 is necessary for cartilage aggrecan degradation in an inflammatory environment
High resolution mapping in the major histocompatibility complex region identifies multiple independent novel loci for psoriatic arthritis
The cannabinoid WIN55, 212-2 abrogates dermal fibrosis in scleroderma bleomycin model
Presence of lymphocyte aggregates in the synovium of patients with early arthritis in relationship to diagnosis and outcome
Granulomatosis with polyangiitis (Wegener's)
Tumour necrosis factor alpha blockade is associated with sustained regression of carotid intima-media thickness for patients with active psoriatic arthritis
A polymorphism rs17336700 in the PSMD7 gene is associated with ankylosing spondylitis in Chinese subjects
Are there specific genetic risk factors for the different forms of ANCA-associated vasculitis?
Autoantibodies in twins discordant for rheumatoid arthritis
Joint destruction in early rheumatoid arthritis over 8 years is similar in women and men despite apparently higher disease activity and poorer function in women
Analysis of the REL polymorphism rs13031237 in autoimmune diseases
Etanercept plus ciclosporin versus etanercept plus methotrexate for maintaining clinical control over psoriatic arthritis
A comparison between the simplified erosion and narrowing score and the Sharp–van der Heijde score
Correction